Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,545
Award facts
- Contract value 100% obligated
- $33,544.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a $33,544.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 26, 2025, with an ultimate completion date of December 29, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the single-award prime vendor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes regional prime vendor contractors to supply pharmaceuticals to Department of Defense healthcare facilities worldwide. The parent indefinite delivery contract, designated SPE2DR and awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, positioning the company as a critical supplier within the federal military medical supply chain.
Under this delivery order, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support DOD healthcare operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals across multiple therapeutic categories. As a woman-owned small business with a track record of consistent contract performance and substantial federal contracting activity, DMS Pharmaceutical Group leverages its established capabilities to fulfill the diverse and specialized pharmaceutical requirements of military healthcare facilities.
Quick answers
Who was awarded contract SPE2DU26FENXY?
SPE2DU26FENXY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DU26FENXY worth?
The government has obligated $33,545 on SPE2DU26FENXY.
Is contract SPE2DU26FENXY an order under another contract?
Yes. SPE2DU26FENXY is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXY competed?
The extent of competition for SPE2DU26FENXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award